{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:33:53Z","timestamp":1779114833503,"version":"3.51.4"},"reference-count":27,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3201\/eid2301.151787","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T19:41:51Z","timestamp":1481658111000},"page":"46-55","source":"Crossref","is-referenced-by-count":9,"title":["Modeling Tool for Decision Support during Early Days of an Anthrax Event"],"prefix":"10.3201","volume":"23","author":[{"given":"Gabriel","family":"Rainisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin I.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Shadomy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Bower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Hupert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2301.151787-201612140834-R1","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management.","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"key-10.3201\/eid2301.151787-201612140834-R2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.151787-201612140834-R3","first-page":"139","article-title":"Mass prophylaxis dispensing concerns: traffic and public access to PODs.","volume":"9","author":"Baccam","year":"2011","journal-title":"Biosecur Bioterror"},{"key":"key-10.3201\/eid2301.151787-201612140834-R4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/0272989X09341389","article-title":"Predicting hospital surge after a large-scale anthrax attack: a model-based analysis of CDC\u2019s cities readiness initiative prophylaxis recommendations.","volume":"29","author":"Hupert","year":"2009","journal-title":"Med Decis Making"},{"key":"key-10.3201\/eid2301.151787-201612140834-R5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/bsp.2005.3.348","article-title":"Evaluation of public health interventions for Anthrax: a report to the secretary\u2019s council on Public Health Preparedness.","volume":"3","author":"Wein","year":"2005","journal-title":"Biosecur Bioterror"},{"key":"key-10.3201\/eid2301.151787-201612140834-R6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/0272989X07312721","article-title":"Modeling the logistics of response to anthrax bioterrorism.","volume":"28","author":"Zaric","year":"2008","journal-title":"Med Decis Making"},{"key":"key-10.3201\/eid2301.151787-201612140834-R7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.epidem.2010.06.001","article-title":"Re-assessment of mitigation strategies for deliberate releases of anthrax using a real-time outbreak characterization tool.","volume":"2","author":"Egan","year":"2010","journal-title":"Epidemics"},{"key":"key-10.3201\/eid2301.151787-201612140834-R8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3201\/eid1007.030623","article-title":"Estimating time and size of bioterror attack.","volume":"10","author":"Walden","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.151787-201612140834-R9","unstructured":"Centers for Disease Control and Prevention. Strategic National Stockpile (SNS) [cited 2015 Apr 1]. http:\/\/www.cdc.gov\/phpr\/stockpile\/stockpile.htm"},{"key":"key-10.3201\/eid2301.151787-201612140834-R10","doi-asserted-by":"publisher","first-page":"20150096","DOI":"10.1098\/rsif.2015.0096","article-title":"A review of back-calculation techniques and their potential to inform mitigation strategies with application to non-transmissible acute infectious diseases.","volume":"12","author":"Egan","year":"2015","journal-title":"J R Soc Interface"},{"key":"key-10.3201\/eid2301.151787-201612140834-R11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/bsp.2011.0005","article-title":"Public response to an anthrax attack: reactions to mass prophylaxis in a scenario involving inhalation anthrax from an unidentified source.","volume":"9","author":"SteelFisher","year":"2011","journal-title":"Biosecur Bioterror"},{"key":"key-10.3201\/eid2301.151787-201612140834-R12","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979.","volume":"266","author":"Meselson","year":"1994","journal-title":"Science"},{"key":"key-10.3201\/eid2301.151787-201612140834-R13","doi-asserted-by":"publisher","first-page":"7589","DOI":"10.1073\/pnas.0509551103","article-title":"Sverdlovsk revisited: modeling human inhalation anthrax.","volume":"103","author":"Wilkening","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2301.151787-201612140834-R14","doi-asserted-by":"publisher","first-page":"e1003555","DOI":"10.1371\/journal.ppat.1003555","article-title":"Quantitative models of the dose-response and time course of inhalational anthrax in humans.","volume":"9","author":"Toth","year":"2013","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2301.151787-201612140834-R15","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/infdis\/166.5.1184","article-title":"Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys.","volume":"166","author":"Kelly","year":"1992","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2301.151787-201612140834-R16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/421491","article-title":"US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax.","volume":"39","author":"Meyerhoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2301.151787-201612140834-R17","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.","volume":"103","author":"Vietri","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2301.151787-201612140834-R18","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3201\/eid0810.020331","article-title":"Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001.","volume":"8","author":"Jefferds","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.151787-201612140834-R19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"Systematic review: a century of inhalational anthrax cases from 1900 to 2005.","volume":"144","author":"Holty","year":"2006","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid2301.151787-201612140834-R20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jama.287.7.863","article-title":"Fatal inhalational anthrax in a 94-year-old Connecticut woman.","volume":"287","author":"Barakat","year":"2002","journal-title":"JAMA"},{"key":"key-10.3201\/eid2301.151787-201612140834-R21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3201\/eid2002.130687","article-title":"Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.","volume":"20","author":"Hendricks","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.151787-201612140834-R22","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.151787-201612140834-R23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.69554\/YIWB8653","article-title":"Logistics modelling: improving resource management and public information strategies in Florida.","volume":"5","author":"Walsh","year":"2011","journal-title":"J Bus Contin Emer Plan"},{"key":"key-10.3201\/eid2301.151787-201612140834-R24","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.","volume":"8","author":"Shepard","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2301.151787-201612140834-R25","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1073\/pnas.1631983100","article-title":"Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak.","volume":"100","author":"Brookmeyer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2301.151787-201612140834-R26","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2301.151787-201612140834-R27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/0272989X08315245","article-title":"Modeling the incubation period of inhalational anthrax.","volume":"28","author":"Wilkening","year":"2008","journal-title":"Med Decis Making"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/23\/1\/15-1787_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T15:09:34Z","timestamp":1749827374000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/23\/1\/15-1787_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2301.151787","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}